ISELIN, N.J., Nov. 20 /PRNewswire-FirstCall/ -- SyntheMed, Inc. , a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, today announced that President and CEO Robert P. Hickey will present at the 2007 Lazard Capital Markets Fourth Annual Healthcare Conference at the Palace Hotel in New York City on Wednesday, November 28, 2007 at 1:30 p.m. EST.
Lazard Capital Markets will host a web cast of the presentation live and by replay at www.wsw.com/webcast/lz4/symd. The presentation can also be accessed at www.synthemed.com. Access to the web cast is not password protected.
About SyntheMed, Inc.
SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products. The company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology.
CONTACT: Gregory Tiberend, +1-212-827-0020, gtiberend@rlcinc.com, or Mary
Kate Dubuss, mkdubuss@rlcinc.com, both of Richard Lewis Communications,
Inc., for SyntheMed, Inc.
Web site: http://www.synthemed.com/
http://www.wsw.com/webcast/lz4/symd/
